Insider Trading & Ownership - Neurogene Inc. (NGNE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Neurogene Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-15
Purchase
2023-08-17
5:08 pm
Neoleukin Therapeutics Inc.NLTXBAKER BROS. ADVISORS LP
667 L.P.
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Director
10% Owner
2,285,342$0.64038$1,463,4875,617,469
(Indirect
Direct)
View
2023-08-11
Sale
2023-08-14
4:06 pm
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Interim CFO, Prin Acct Off
1,323$0.6184$81821,637
(Direct)
View
2023-04-03
Sale
2023-04-04
8:51 pm
Neoleukin Therapeutics Inc.NLTXPatel Priti
Former Chief Medical Officer
3,769$0.6919$2,60837,313
(Direct)
View
2023-02-02
Sale
2023-02-03
4:33 pm
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Principal Accounting Officer
3,316$0.5972$1,98028,460
(Direct)
View
2023-02-02
Sale
2023-02-03
4:32 pm
Neoleukin Therapeutics Inc.NLTXPatel Priti
Chief Medical Officer
14,380$0.5972$8,58866,082
(Direct)
View
2022-08-10
Sale
2022-08-12
5:24 pm
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Principal Accounting Officer
1,655$0.9914$1,64111,776
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-14
Option Award
2024-06-17
2:37 pm
N/A
2034-06-14
Neurogene Inc.NGNEWoods Robert Keith
Director
7,700$07,700
(Direct)
View
2024-06-14
Option Award
2024-06-17
2:37 pm
N/A
2034-06-14
Neurogene Inc.NGNEPALEKAR ROHAN
Director
7,700$07,700
(Direct)
View
2024-06-14
Option Award
2024-06-17
2:36 pm
N/A
2034-06-14
Neurogene Inc.NGNEBAFFI ROBERT
Director
7,700$07,700
(Direct)
View
2024-06-14
Option Award
2024-06-17
2:36 pm
N/A
2034-06-14
Neurogene Inc.NGNENoonberg Sarah B.
Director
7,700$07,700
(Direct)
View
2024-06-14
Option Award
2024-06-17
2:35 pm
N/A
2034-06-14
Neurogene Inc.NGNEFreedland Cory S.
Director
7,700$07,700
(Direct)
View
2024-03-13
Option Award
2024-03-14
8:54 pm
N/A
2034-03-13
Neurogene Inc.NGNEMcMinn Rachel
Chief Executive Officer
93,282$093,282
(Direct)
View
2024-03-13
Option Award
2024-03-14
8:53 pm
N/A
2034-03-13
Neurogene Inc.NGNECvijic Christine Mikail
President and CFO
85,803$0106,744
(Direct)
View
2024-03-13
Option Award
2024-03-14
8:51 pm
N/A
2034-03-13
Neurogene Inc.NGNECobb Stuart
Chief Scientific Officer
54,841$054,841
(Direct)
View
2024-01-16
Option Award
2024-01-18
7:01 pm
N/A
2034-01-16
Neurogene Inc.NGNEWoods Robert Keith
Director
15,400$015,400
(Direct)
View
2024-01-16
Option Award
2024-01-18
6:58 pm
N/A
2034-01-16
Neurogene Inc.NGNEPALEKAR ROHAN
Director
15,400$015,400
(Direct)
View
2024-01-16
Option Award
2024-01-18
6:56 pm
N/A
2034-01-16
Neurogene Inc.NGNENoonberg Sarah B.
Director
15,400$015,400
(Direct)
View
2024-01-16
Option Award
2024-01-18
6:53 pm
N/A
2034-01-16
Neurogene Inc.NGNEFreedland Cory S.
Director
15,400$015,400
(Direct)
View
2024-01-16
Option Award
2024-01-18
6:51 pm
N/A
2034-01-16
Neurogene Inc.NGNEBAFFI ROBERT
Director
15,400$015,400
(Direct)
View
2024-01-16
Option Award
2024-01-18
6:48 pm
N/A
2034-01-16
Neurogene Inc.NGNEJordan Julie
Chief Medical Officer
75,000$075,000
(Direct)
View

Ownership
2023-12-26
6:16 pm
N/A
N/A
Neurogene Inc.NGNECvijic Christine Mikail
President and CFO
0$0126,750
(Direct)
View

Ownership
2023-12-26
6:12 pm
N/A
N/A
Neurogene Inc.NGNEMcMinn Rachel
Chief Executive Officer
0$01,314,558
(Direct)
View

Ownership
2023-12-26
6:10 pm
N/A
2030-10-15
Neurogene Inc.NGNEBAFFI ROBERT
Director
0$011,642
(Direct)
View

Ownership
2023-12-26
6:05 pm
N/A
2030-10-15
Neurogene Inc.NGNECobb Stuart
Chief Scientific Officer
0$074,226
(Direct)
View
2023-12-18
Option Award
2023-12-20
6:43 pm
N/A
N/A
Neurogene Inc.NGNEBAKER BROS. ADVISORS LP
667 L.P.
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Former 10% Owner
Director
2,877,250$07,831,766
(Indirect)
View
2023-10-05
Exercise
2023-10-10
4:22 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXBAKER BROS. ADVISORS LP
667 L.P.
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Director
10% Owner
592,650$03,363,045
(Indirect)
View
2023-08-10
Exercise
2023-08-14
4:06 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Interim CFO, Prin Acct Off
5,000$021,637
(Direct)
View
2023-06-08
Option Award
2023-06-12
4:03 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXBAKER BROS. ADVISORS LP
667 L.P.
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Director
50,000$050,000
(Indirect)
View
2023-06-08
Option Award
2023-06-09
4:28 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXSIMPSON TODD E
Director
25,000$025,000
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:27 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXPALEKAR ROHAN
Director
25,000$025,000
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:26 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXNoonberg Sarah B.
Director
25,000$025,000
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:25 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXLavelle Erin
Director
25,000$025,000
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:24 pm
N/A
2033-06-07
Neoleukin Therapeutics Inc.NLTXBabler Martin
Director
25,000$025,000
(Direct)
View
2023-03-31
Exercise
2023-04-04
8:51 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXPatel Priti
Former Chief Medical Officer
10,000$037,313
(Direct)
View
2023-02-01
Exercise
2023-02-03
4:33 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Principal Accounting Officer
12,500$028,460
(Direct)
View
2023-02-01
Exercise
2023-02-03
4:32 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXPatel Priti
Chief Medical Officer
35,000$066,082
(Direct)
View
2022-08-10
Exercise
2022-08-12
5:24 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Principal Accounting Officer
5,000$011,776
(Direct)
View
2022-08-02
Option Award
2022-08-04
4:43 pm
N/A
2032-08-01
Neoleukin Therapeutics Inc.NLTXWalkey Carl
Senior Vice President
150,000$0150,000
(Direct)
View
2022-08-02
Option Award
2022-08-04
4:41 pm
N/A
2032-08-01
Neoleukin Therapeutics Inc.NLTXSmith Sean Michael
Principal Accounting Officer
150,000$0150,000
(Direct)
View
2022-08-02
Option Award
2022-08-04
4:40 pm
N/A
2032-08-01
Neoleukin Therapeutics Inc.NLTXPatel Priti
Chief Medical Officer
250,000$0250,000
(Direct)
View
2022-08-02
Option Award
2022-08-04
4:38 pm
N/A
2032-08-01
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
350,000$0350,000
(Direct)
View
2022-08-02
Option Award
2022-08-04
4:37 pm
N/A
2032-08-01
Neoleukin Therapeutics Inc.NLTXCochener Donna
General Counsel, SVP Legal
100,000$0100,000
(Direct)
View
Goto 0, 1, 2, Next